117673 ⎘
Carbon-oxygen lyases (4.2); Hydro-lyases (4.2.1) Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
COMPOSITIONS AND METHODS COMPRISING PLANTS WITH MODIFIED SEED COMPOSITION
#2RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF GLYCERIC ACID AND DOWNSTREAM PRODUCTS
#3PROMOTER OF Eno1 GENE
#4USE OF ALPHA-ENOLASE ANTAGONIST FOR TREATING ANGIOGENESIS-RELATED DISEASES
#5Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals
#6CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY AND METHOD FOR PRODUCING L-LYSINE BY USING SAME
#7DNA VACCINE FOR USE IN THE THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF TUMOR DISEASES
#8GENETICALLY MODIFIED AZOTOBACTER VINELANDII STRAINS AND METHODS OF USING SAME
#9RECOMBINANT MICROORGANISM HAVING IMPROVED ABILITY TO PRODUCE RECOMBINANT SILK PROTEIN AND METHOD FOR PRODUCING HIGH-MOLECULAR-WEIGHT RECOMBINANT SILK PROTEIN BY USING SAME
#10SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS
#11MODULAR PLATFORM FOR PROGRAMMABLE SPATIOTEMPORAL BIOMOLECULE CLUSTERING WITH APPLICATIONS INCLUDING ENHANCED METABOLIC YIELD
#12ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF 3,4-DIHYDROXYBENZOIC ACID BY FERMENTATION
#13CHIMERIC RECOMBINANT PROTEIN ENCODING EPITOPES WITH IDENTITY TO BACTERIAL, FUNGAL, PARASITE AND HUMAN METABOLIC ENZYMES INVOLVED IN PATHOGENESIS DURING SEXUALLY TRANSMITTED INFECTIONS
#14EPITOPES
#15ENGINEERED T-CELLS CO-EXPRESSING AN ANTI-BCMA CAR AND AN ANTI-ECTOENZYME ANTIBODY AND THEIR USE IN THE TREATMENT OF CANCER
#16ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#17Antibodies against infectious diseases
#18Recombinant host cells and methods for the production of glyceric acid and downstream products
#19NOVEL COMPLEXES OF TYPES OF MHC CLASS II THAT BIND TO COLLAGEN TYPE II PEPTIDES AND THEIR USE ON DIAGNOSIS AND TREATMENT
#20Bioconversion of short-chain hydrocarbons to fuels and chemicals
#21Anti-tumour immune responses to modified self-epitopes
#22Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#23Agents and methods for diagnosing fish allergy
#24ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#25Enolase 1 (ENO1) compositions and uses thereof
#26COMPOSITIONS AND USES THEREOF
#27A NOVEL INVADOPODIA-SPECIFIC MARKER OF INVASIVE CANCER STEM CELLS AND THE USE THEREOF
#28Recombinant microorganisms capable of carbon fixation
#29BIOCONVERSION OF SHORT-CHAIN HYDROCARBONS TO FUELS AND CHEMICALS
#30Antibodies against infectious diseases
#31Selection in fungi
#32Anti-tumour immune responses to modified self-epitopes
#33Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same
#34Methods for efficient production of polyunsaturated fatty acids (PUFA) in and species
#35Recombinant microorganisms capable of carbon fixation
#36CELL-FREE SYSTEM FOR CONVERTING METHANE INTO FUEL AND CHEMICAL COMPOUNDS
#37Selection in fungi
#38ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#39COMPOSITIONS COMPRISING ENO1 AND THEIR USE IN METHODS OF TREATING OBESITY OR OVERWEIGHT AND REDUCING WEIGHT GAIN
#40Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#41Synthetic peptides for the treatment of autoimmune diseases
#42Enolase 1 (Eno1) compositions and uses thereof
#43Enolase 1 (Eno1) compositions and uses thereof
#44NOVEL PEPTIDES THAT BIND TO TYPES OF MHC CLASS II AND THEIR USE ON DIAGNOSIS AND TREATMENT
#45Collateral gene inactivation biomarkers and targets for cancer therapy
#46promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy
#47promoters, and the use thereof to direct expression of proteins in yeast, preferably using a haploid mating strategy
#48Isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof
#49Antigens and antibodies associated to pancreatic ductal adenocarcinoma
#50Composition for Prevention, Treatment, and Diagnosis of Chronic Inflammatory Airway Diseases
#51ADH promoter and use thereof to direct expression of proteins
#52Feline infectious peritonitis (FIP) and systemic multi-organ coronavirus biomarkers and screening methods